Troxipide(曲昔匹特) is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum.

Rebamipide(瑞巴派特) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.

Etilefrine hydrochloride(盐酸依替福林) is a phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

Cinoxacin(西诺沙星) is a chemotherapeutic agent that inhibits bacterial DNA synthesis.

Trimetazidine dihydrochloride(盐酸曲美他嗪) is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.

CP-91149 is a selective glycogen phosphorylase (GP) inhibitor.

Dabigatran is a potent nonpeptide thrombin inhibitor.

N6-methyladenosine(N6-甲基腺苷) is a base modified analog of adenosine and is found as a minor nucleoside in natural RNAs.